Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
Titel:
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
Auteur:
Loriot, Y. Bianchini, D. Ileana, E. Sandhu, S. Patrikidou, A. Pezaro, C. Albiges, L. Attard, G. Fizazi, K. De Bono, J.S. Massard, C.